The Role of Hydrea in Drug-Resistant CML Treatment Chronic Myeloid Leukemia (CML) has seen remarkable advancements with targeted therapies, but drug resistance remains a clinical challenge in some patients. In such complex cases, maintaining access through a trusted Hydrea supplier becomes essential to support supportive treatment strategies and effective blood count control during resistant phases of the disease.
Understanding Drug-Resistant...
0 condivisioni
2290 Views